Phase II Study of Amrubicin As Second-Line Therapy in Patients With Platinum-Refractory Small-Cell Lung Cancer Article

Industry Collaboration International Collaboration

cited authors

  • Ettinger, David S.; Jotte, Robert; Lorigan, Paul; Gupta, Vicram; Garbo, Lawrence; Alemany, Carlos; Conkling, Paul; Spigel, David R.; Dudek, Arkadiusz Z.; Shah, Chirag; Salgia, Ravi; McNally, Richard; Renschler, Markus F.; Oliver, Jennifer W.

authors

Publication Date

  • May 20, 2010

webpage

published in

category

start page

  • 2598

end page

  • 2603

volume

  • 28

issue

  • 15